These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9330022

  • 1. The effect of citalopram in panic disorder.
    Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T.
    Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022
    [Abstract] [Full Text] [Related]

  • 2. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [Abstract] [Full Text] [Related]

  • 3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 4. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y, Bakker A, Dunbar G, Judge R.
    Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680
    [Abstract] [Full Text] [Related]

  • 5. Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial.
    Leinonen E, Lepola U, Koponen H, Turtonen J, Wade A, Lehto H.
    J Psychiatry Neurosci; 2000 Jan; 25(1):24-32. PubMed ID: 10721681
    [Abstract] [Full Text] [Related]

  • 6. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder.
    Lepola UM, Wade AG, Leinonen EV, Koponen HJ, Frazer J, Sjödin I, Penttinen JT, Pedersen T, Lehto HJ.
    J Clin Psychiatry; 1998 Oct; 59(10):528-34. PubMed ID: 9818634
    [Abstract] [Full Text] [Related]

  • 7. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y, Judge R.
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [Abstract] [Full Text] [Related]

  • 8. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
    Sasson Y, Iancu I, Fux M, Taub M, Dannon PN, Zohar J.
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
    [Abstract] [Full Text] [Related]

  • 9. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH, Goa KL.
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [Abstract] [Full Text] [Related]

  • 10. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM, Gergel I, Li D.
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [Abstract] [Full Text] [Related]

  • 11. Citalopram for treatment-resistant obsessive-compulsive disorder.
    Pallanti S, Quercioli L, Paiva RS, Koran LM.
    Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
    [Abstract] [Full Text] [Related]

  • 12. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A, van Dyck R, Spinhoven P, van Balkom AJ.
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB, Dahl AA.
    Eur Arch Psychiatry Clin Neurosci; 1999 Dec; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. French University Antidepressant Group.
    Caillard V, Rouillon F, Viel JF, Markabi S.
    Acta Psychiatr Scand; 1999 Jan; 99(1):51-8. PubMed ID: 10066007
    [Abstract] [Full Text] [Related]

  • 15. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M, Wistedt B.
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [Abstract] [Full Text] [Related]

  • 16. The role of SSRIs in panic disorder.
    Sheehan DV, Harnett-Sheehan K.
    J Clin Psychiatry; 1996 Jun; 57 Suppl 10():51-8; discussion 59-60. PubMed ID: 8917132
    [Abstract] [Full Text] [Related]

  • 17. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP.
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [Abstract] [Full Text] [Related]

  • 18. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN, Iancu I, Lowengrub K, Gonopolsky Y, Musin E, Grunhaus L, Kotler M.
    Clin Neuropharmacol; 2007 Jan; 30(6):326-34. PubMed ID: 18090457
    [Abstract] [Full Text] [Related]

  • 19. Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo.
    Bandelow B, Stein DJ, Dolberg OT, Andersen HF, Baldwin DS.
    Pharmacopsychiatry; 2007 Jul; 40(4):152-6. PubMed ID: 17694478
    [Abstract] [Full Text] [Related]

  • 20. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S, van Rheede van Oudtshoorn E, Muller JE, Mohr N, Stein DJ.
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.